Gnubiotics and Lymphatica win the second stage of Venture Kick
30.05.2017
The two startup projects and their teams win CHF 20’000 each. They are now getting ready for the program’s final where they might win CHF 130’000 in total.
 The team of Gnubiotics
|
 |
 The team of Lymphatica: Marco Pisano and Valentina Triacca
|
|
Gnubiotics (BioArk) - Biotech: GNUbiotics Sciences, a Valais Switzerland biotech startup created in September 2016, is active in research and development to reproduce the natural diversity and complexity of unique structures found in breast milk that are beneficial in preventing infections and onset of diet induced obesity. The first pipeline candidate GNU100, an Oligosaccharide, will be sold as Functional Nutritional ingredient for the Pet Food market.
Lymphatica (CHUV, EPFL) – Medtech: Lymphatica is a medical device development company that has designed the first implantable system for chronic lymphedema treatment, which intend to produce and market. Chronic lymphedema is a common side effect of cancer therapies that causes chronic swelling of the limbs, pain and recurrent infections, leading to a state of chronic disability for millions of people in the world.